Evidence map›Paper›PMID 35073310›Full record

ArticlePLoS biology2022

Endogenously produced catecholamines improve the regulatory function of TLR9-activated B cells.

Nadine Honke, Torsten Lowin, Birgit Opgenoorth, Namir Shaabani, Alexander Lautwein, John R Teijaro, Matthias Schneider, Georg Pongratz

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Dopaminergic signalling in gastrointestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  4. Expansion of B10 cellsInternational journal of molecular medicine · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  12. Roles of Mitochondrial DNA Damage in Kidney Diseases: A New Biomarker.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nadine HonkeDepartment of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany.ORCID 0000-0002-2220-6806
Torsten LowinDepartment of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany.ORCID 0000-0001-7368-2776
Birgit OpgenoorthDepartment of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany.
Namir ShaabaniDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America.
Alexander LautweinDepartment of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany.
John R TeijaroDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America.
Matthias SchneiderDepartment of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany.
Georg PongratzDepartment of Rheumatology, Hiller Research Center Rheumatology, University Hospital Düsseldorf, Germany.ORCID 0000-0002-2185-8458
Düsseldorf University Hospital · DEScripps Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sympathetic nervous system (SNS) contributes to immune balance by promoting anti-inflammatory B cells. However, whether B cells possess a self-regulating mechanism by which they modulate regulatory B cell (Breg) function is not well understood. In this study, we investigated the ability of B cells to synthesize their own catecholamines upon stimulation with different B cell activators and found that expression of the enzyme tyrosine hydroxylase (TH), required to generate catecholamines, is up-regulated by Toll-like receptor (TLR)9. This TLR9-dependent expression of TH correlated with up-regulation of adrenergic receptors (ADRs), enhanced interleukin (IL)-10 production, and overexpression of the co-inhibitory ligands programmed death ligand 1 (PD-L1) and Fas ligand (FasL). Moreover, concomitant stimulation of ß1-3-ADRs together with a B cell receptor (BCR)/TLR9 stimulus clearly enhances the anti-inflammatory potential of Bregs to suppress CD4 T cells, a crucial population in the pathogenesis of autoimmune diseases, like rheumatoid arthritis (RA). Furthermore, TH up-regulation was also demonstrated in B cells during the course of collagen-induced arthritis (CIA), a mouse model for the investigation of RA. In conclusion, our data show that B cells possess an autonomous mechanism to modulate their regulatory function in an autocrine and/or paracrine manner. These findings help to better understand the function of B cells in the regulation of autoimmune diseases and the interplay of SNS.

Indexed as

AnimalsArthritis, ExperimentalArthritis, RheumatoidB7-H1 AntigenB-Lymphocytes, RegulatoryCatecholaminesCollagenDisease Models, AnimalFas Ligand ProteinInterleukin-10Lymphocyte ActivationMaleMiceMice, KnockoutToll-Like Receptor 9Tyrosine 3-MonooxygenaseB7-H1 AntigenCatecholaminesCollagenFas Ligand ProteinInterleukin-10Toll-Like Receptor 9Tyrosine 3-Monooxygenase

Identifiers

PMID35073310
PMCPMC8786184
OpenAlexW4210778738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.